21 results
424B5
GLUE
Monte Rosa Therapeutics Inc
26 Oct 23
Prospectus supplement for primary offering
4:55pm
to the shares of our common stock underlying such pre-funded warrants including with respect to dividends and voting rights. Upon exercise of the pre … common stock do not have any cumulative voting rights. Holders of our common stock are entitled to receive ratably any dividends declared by our board
PRE 14A
vybe p7dojh
12 Apr 23
Preliminary proxy
4:07pm
S-3
m22ls
1 Jul 22
Shelf registration
5:01pm
DEF 14A
qek 5e164
27 Apr 22
Definitive proxy
4:10pm
10-K
EX-4.2
o6o9yvnif0ze if4uo5q
29 Mar 22
Annual report
4:15pm
8-K
EX-3.2
wa5r9xigi6j pnc
28 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:24pm
424B4
rfeyyi0zlzxs4ht96z9w
25 Jun 21
Prospectus supplement with pricing info
6:08am
S-1/A
vc8ze2zldduitt
9 Jun 21
IPO registration (amended)
4:51pm
S-1
EX-10.1
ck4pq9 8ten01cfj6ccd
4 Jun 21
IPO registration
9:07am
S-1
xgu9k h26t3gsz9
4 Jun 21
IPO registration
9:07am
S-1
EX-3.4
1br4gy 45lfd41gvxv
4 Jun 21
IPO registration
9:07am
S-1
EX-10.5
guclak h6vd
4 Jun 21
IPO registration
9:07am
S-1
EX-10.6
7cbugfftqgthge3n1 pm
4 Jun 21
IPO registration
9:07am
DRS/A
ud6icrk6y
21 May 21
Draft registration statement (amended)
12:00am
DRS
a5pg 0udiei3rvs2
19 Apr 21
Draft registration statement
12:00am